National Center for Advancing Translational Sciences

Recent papers from National Center for Advancing Translational Sciences

1. Syncytiotrophoblast differentiation defects drive ER stress and reprogram placental PSG1 glycosylation in preeclampsiaMolecular Biomedicine · 2026
2. Metformin at the Time of COVID‐19 Infection and Risk of Long COVID: A Target Trial Emulation StudyJournal of Medical Virology · 2026
3. Cbfβ regulates DNA looping at the Il4-Il13 loci to control their differential expression in Th2 cellsThe Journal of Experimental Medicine · 2026
4. A fibril-selective single-domain antibody targets pathogenic amyloid-β assemblies and protects human neuronsiScience · 2026
5. Genotype-specific molecular and functional trajectories in NGLY1 deficiency: a comparative multi-omics study of patient-derived iPSC neuronsFrontiers in Cell and Developmental Biology · 2026
6. Integrating in silico ADME modeling with Tox21 toxicity profiling to support compound prioritizationScientific Reports · 2026
7. Metabolomic Profiles Reproducibly Differentiate Heterogeneous Sample Mixtures: A Multi-Lab “Round-Robin” StudyAnalytical Chemistry · 2026
8. Advances in 3D Bioprinting for Breast Cancer Modeling: Tumor Microenvironment, Metastasis, and Drug ScreeningAdvanced Healthcare Materials · 2026
9. Advancements in Forecasting Liver Cytosol Metabolic Stability: A Comprehensive Update on Machine Learning Predictive ModelsBioinformatics Advances · 2026
10. Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational ModelingMolecules · 2026
11. RNF5 Regulates HERP1 and OS9 Stability and Modulates Processing of an ERAD SubstrateLife · 2026
12. Integrating Tox21 Assay Data and Chemical Fingerprints for Neurotoxicity PredictionChemical Research in Toxicology · 2026
13. What’s next for metabolomics?Current Opinion in Biotechnology · 2026
14. Data-driven identification of repurposable drugs for ALSnpj Digital Medicine · 2026
15. A framework for selecting, validating, and optimizing DHT-derived measures in clinical researchnpj Digital Medicine · 2026
16. Rebuttal to Correspondence on “PFAS Toxicity: What’s True, What’s Not, and What Really Matters”Environmental Science & Technology · 2026
17. Toxicologic Pathology Forum: ESTP/STP Working Group Opinion on the Evolving Landscape of New Approach Methodologies in Drug and Chemical Safety DevelopmentToxicologic Pathology · 2026
18. Developing the Dopamine D3 Receptor (D3R) Antagonist, ( R )‐VK4‐116, as a Non‐Opioid Medication for the Treatment of Opioid Use DisorderMedicinal Research Reviews · 2026
19. Establishment of induced pluripotent stem cell line TRNDi045-A-38 carrying homozygous DOK7-related Congenital Myasthenia patient-mutation knock-in variant from parental KOLF2.1JStem Cell Research · 2026
20. Cellular modifiers of TDP-43 phase transition and cytoplasmic aggregationeLife · 2026